In CRC, SPARC showed the highest expression (Figure S1a), followed by VIM, COL12A1 (SE = 18.3), DKK3 (SE = 13.9), ACTA2, INHBA (SE = 20.9), ANTXR1 (SE = 24.3), PDGFRB (SE = 14.8), FAP, SLC24A3 (SE = 23.6), ITGA11 (SE = 16.4), MMP2 (SE = 18.4), CCL2 (SE = 18.0), POSTN (SE = 15.4), PDPN (SE = 11.2), and LRRC15 (SE = 10.5). This evidence concerns the gene CCL2 and colorectal carcinoma.